Quick Answer
Denali Therapeutics Inc. reported Total Revenue of $0.00 for the year ending 2025.
- This data is from Denali Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $0.00 | Q3 2017: $0.00 | Q1 2018: $641.0 thousand | Q1 2018: $641.0 thousand | Q2 2018: $1.65 million | Q3 2018: $1.20 million | Q4 2018: $125.68 million | Q1 2019: $4.11 million | Q1 2019: $4.21 million | Q2 2019: $4.10 million | Q2 2019: $4.20 million | Q3 2019: $13.51 million | Q3 2019: $13.60 million | Q4 2019: $4.67 million | Q1 2020: $3.55 million | Q1 2020: $3.60 million | Q2 2020: $5.85 million | Q2 2020: $5.81 million | Q3 2020: $9.39 million | Q3 2020: $9.39 million | Q1 2021: $7.92 million | Q1 2021: $7.92 million | Q2 2021: $22.94 million | Q2 2021: $22.94 million | Q3 2021: $5.29 million | Q3 2021: $5.29 million | Q1 2022: $42.14 million | Q1 2022: $42.14 million | Q2 2022: $52.48 million | Q2 2022: $52.48 million | Q3 2022: $184.0 thousand | Q3 2022: $3.56 million | Q1 2023: $35.14 million | Q1 2023: $35.14 million | Q2 2023: $294.12 million | Q2 2023: $294.12 million | Q3 2023: $1.27 million | Q3 2023: $1.27 million | Q1 2024: $0.00 | Q1 2024: $0.00 | Q2 2024: $0.00 | Q3 2024: $0.00.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2025: $0.00 | Fiscal year 2024: $0.00 | Fiscal year 2024: $0.00 | Fiscal year 2023: $330.53 million | Fiscal year 2023: $330.53 million | Fiscal year 2022: $108.46 million | Fiscal year 2022: $105.07 million | Fiscal year 2021: $48.66 million | Fiscal year 2021: $48.66 million | Fiscal year 2020: $335.56 million | Fiscal year 2020: $335.66 million | Fiscal year 2019: $26.68 million | Fiscal year 2019: $26.32 million | Fiscal year 2018: $129.16 million | Fiscal year 2018: $129.10 million | Fiscal year 2017: $0.00 | Fiscal year 2016: $0.00.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: